in Newswire Published on October 18, 2016

Class Action Says Mylan Illegally Inflated EpiPen Prices

by Corrado Rizzi

Last Updated on May 8, 2018

Corcoran et al v. Mylan Pharmaceuticals Inc. et al

Filed: October 18, 2016 § 3:16-cv-05983

California and Massachusetts consumers have filed a proposed class action against Mylan claiming the company illegally raised the EpiPen's price by more than 500 percent.

Defendant(s)

Mylan, Inc.

Law(s)

State(s)

Case Spotlight

Hair Relaxer Lawsuits

ClassAction.org Newsletter

Stay Current

Sign Up For
Our Newsletter

New cases and investigations, settlement deadlines, and news straight to your inbox.

This browser does not support PDFs. Please download the PDF to view it: Download PDF.

Last Updated on May 8, 2018 — 6:56 AM

Corrado Rizzi

corrado@classaction.org

Corrado Rizzi is the Senior Managing Editor of ClassAction.org.

About ClassAction.org

ClassAction.org is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.